PPARγ in adipocyte differentiation and metabolism - Novel insights from genome-wide studies

FEBS Letters

Volumn 584, Issue 15, 2010, Pages 3242-3249

  Siersbæk, Rasmus ^a   Nielsen, Ronni ^a   Mandrup, Susanne ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Adipogenesis; C EBP; Chromatin immunoprecipitation; Genome wide; PPAR

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN;

ADIPOCYTE; ADIPOGENESIS; BINDING SITE; CELL DIFFERENTIATION; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; DISEASE COURSE; GENE ACTIVATION; GENOME; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; METABOLIC REGULATION; METABOLIC STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; CYTOLOGY; GENETIC ASSOCIATION; GENETICS; METABOLISM;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PPAR GAMMA;

EID: 77955274518     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.06.010     Document Type: Review

References (86)

1. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9:367-377.
2. Muoio D.M., Newgard C.B. Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9:193-205.
3. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of PPAR gamma. Ann. Rev. Biochem. 2008, 77:289-312.
4. Qatanani M., Lazar M.A. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007, 21:1443-1455.
5. Semple R.K., Chatterjee V.K.K., O'Rahilly S. PPAR gamma and human metabolic disease. J. Clin. Invest. 2006, 116:581-589.
6. Nawrocki A.R., Rajala M.W., Tomas E., Pajvani U.B., Saha A.K., Trumbauer M.E., Pang Z., Chen A.S., Ruderman N.B., Chen H., Rossetti L., Scherer P.E. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 2006, 281:2654-2660.
7. Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K., Umesono K., Akanuma Y., Fujiwara T., Horikoshi H., Yazaki Y., Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 1998, 101:1354-1361.
8. Elabd C., Chiellini C., Carmona M., Galitzky J., Cochet O., Petersen R., Penicaud L., Kristiansen K., Bouloumie A., Casteilla L., Dani C., Ailhaud G., Amri E.Z. Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes. Stem Cells 2009, 27:2753-2760.
9. Petrovic N., Walden T.B., Shabalina I.G., Timmons J.A., Cannon B., Nedergaard J. Chronic peroxisome proliferator-activated receptor gamma (PPAR gamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J. Biol. Chem. 2010, 285:7153-7164.
10. Vernochet C., Peres S.B., Davis K.E., McDonald M.E., Qiang L., Wang H., Scherer P.E., Farmer S.R. C/EBP alpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol. Cell. Biol. 2009, 29:4714-4728.
11. MacDougald O.A., Mandrup S. Adipogenesis: forces that tip the scales. Trends Endocrinol. Metab. 2002, 13:5-11.
12. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 2006, 4:263-273.
13. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., Spiegelman B.M., Mortensen R.M. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 1999, 4:611-617.
14. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., Evans R.M. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 1999, 4:585-595.
15. Wu Z.D., Rosen E.D., Brun R., Hauser S., Adelmant G., Troy A.E., McKeon C., Darlington G.J., Spiegelman B.M. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 1999, 3:151-158.
16. Kim S.W., Her S.J., Kim S.Y., Shin C.S. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem. Biophys. Res. Commun. 2005, 327:811-819.
17. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20:649-688.
18. Bishop-Bailey D., Wray J. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation. Prostaglandins Other Lipid Mediat. 2003, 71:1-22.
19. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001, 142:4195-4202.
20. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294:1866-1870.
21. Chandra V., Huang P., Hamuro Y., Raghuram S., Wang Y., Burris T.P., Rastinejad F. Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA. Nature 2008, 350:356.
22. Bain D.L., Heneghan A.F., Connaghan-Jones K.D., Miura M.T. Nuclear receptor structure: implications for function. Ann. Rev. Physiol. 2007, 69:201-220.
23. Willson T.M., Lambert M.H., Kliewer S.A. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu. Rev. Biochem. 2001, 70:341-367.
24. Picard F., Gehin M., Annicotte J.S., Rocchi S., Champy M.F., O'Malley B.W., Chambon P., Auwerx J. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 2002, 111:931-941.
25. Zhu Y., Qi C., Jain S., Rao M.S., Reddy J.K. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem. 1997, 272:25500-25506.
26. Yuan C.X., Ito M., Fondell J.D., Fu Z.Y., Roeder R.G. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Nat. Acad. Sci. USA 1998, 95:7939-7944.
27. Gelman L., Zhou G., Fajas L., Raspé E., Fruchart J.C., Auwerx J. P300 Interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively. J. Biol. Chem. 1999, 274:7681-7688.
28. van Beekum O., Brenkman A.B., Grontved L., Hamers N., van den Broek N.J.F., Berger R., Mandrup S., Kalkhoven E. The adipogenic acetyltransferase Tip60 targets activation function 1 of peroxisome proliferator-activated receptor gamma. Endocrinology 2008, 149:1840-1849.
29. Grontved L., Madsen M.S., Boergesen M., Roeder R.G., Mandrup S. MED14 tethers mediator to the N-terminal domain of peroxisome proliferator-activated receptor gamma and is required for full transcriptional activity and adipogenesis. Mol. Cell. Biol. 2010, 30:2155-2169.
30. Bugge A., Grontved L., Aagaard M.M., Borup R., Mandrup S. The PPAR gamma 2 A/B-domain plays a gene-specific role in transactivation and cofactor recruitment. Mol. Endocrinol. 2009, 23:794-808.
31. Adams M., Reginato M.J., Shao D.L., Lazar M.A., Chatterjee V.K. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 1997, 272:5128-5132.
32. Zhang B., Berger J., Zhou G.C., Elbrecht A., Biswas S., WhiteCarrington S., Szalkowski D., Moller D.E. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 1996, 271:31771-31774.
33. Rangwala S.M., Rhoades B., Shapiro J.S., Rich A.S., Kim J.K., Shulman G.I., Kaestner K.H., Lazar M.A. Genetic modulation of PPAR gamma phosphorylation regulates insulin sensitivity. Dev. Cell 2003, 5:657-663.
34. von Knethen A., Tzieply N., Jennewein C., Brune B. Casein-kinase-II-dependent phosphorylation of PPAR gamma provokes CRM1-mediated shuttling of PPAR gamma from the nucleus to the cytosol. J. Cell Sci. 2010, 123:192-201.
35. Wang Nd., Milton J.F., Bradley A., Ou C.N., Abdelsayed S.V., Wilde M.D., Taylor L.R., Wilson D.R., Darlington G.J. Impaired energy homeostasis in C/EBPalpha Knockout mice. Science 1995, 269:1108-1112.
36. Linhart H.G., Ishimura-Oka K., DeMayo F., Kibe T., Repka D., Poindexter B., Bick R.J., Darlington G.J. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc. Nat. Acad. Sci. USA 2001, 98:12532-12537.
37. Ossipow V., Descombes P., Schibler U. Ccaat enhancer-binding protein messenger-RNA is translated into multiple proteins with different transcription activation potentials. Proc. Nat. Acad. Sci. USA 1993, 90:8219-8223.
38. Lin F.T., MacDougald O.A., Diehl A.M., Lane M.D. A 30-Kda alternative translation product of the ccaat enhancer-binding protein-alpha message - transcriptional activator lacking antimitotic activity. Proc. Nat. Acad. Sci. USA 1993, 90:9606-9610.
39. Kowenz-Leutz E., Leutz A. A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol. Cell 1999, 4:735-743.
40. Descombes P., Schibler U. A liver-enriched transcriptional activator protein, lap, and a transcriptional inhibitory protein, lip, are translated from the same messenger-RNA. Cell 1991, 67:569-579.
41. Tanaka T., Yoshida N., Kishimoto T., Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 1997, 16:7432-7443.
42. Freytag S.O., Geddes T.J. Reciprocal regulation of adipogenesis by Myc and C/Ebp-alpha. Science 1992, 256:379-382.
43. Lin F.T., Lane M.D. Antisense Ccaat enhancer-binding protein RNA suppresses coordinate gene-expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev. 1992, 6:533-544.
44. Muller C., Calkhoven C.F., Sha X.J., Leutz A. The CCAAT enhancer-binding protein alpha (C/EBP alpha) requires a SWI/SNF complex for proliferation arrest. J. Biol. Chem. 2004, 279:7353-7358.
45. Tang Q.Q., Otto T.C., Lane M.D. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc. Nat. Acad. Sci. USA 2003, 100:850-855.
46. Karamanlidis G., Karamitri A., Docherty K., Hazlerigg D.G., Lomax M.A. C/EBP beta reprograms white 3T3-L1 preadipocytes to a brown adipocyte pattern of gene expression. J. Biol. Chem. 2007, 282:24660-24669.
47. Green H., Kehinde O. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1974, 1:113-116.
48. Green H., Kehinde O. Established pre-adipose cell line and its differentiation in culture. 2. Factors affecting adipose conversion. Cell 1975, 5:19-27.
49. Salma N., Xiao H., Imbalzano A.N. Temporal recruitment of CCAAT/enhancer-binding proteins to early and late adipogenic promoters in vivo. J. Mol. Endocrinol. 2006, 36:139-151.
50. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., Spiegelman B.M. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002, 16:22-26.
51. Chen Z., Torrens J.I., Anand A., Spiegelman B.M., Friedman J.M. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and -independent mechanisms. Cell Metab. 2005, 1:93-106.
52. Birsoy K.I., Chen Z., Friedman J. Transcriptional regulation of adipogenesis by KLF4. Cell Metab. 2008, 7:339-347.
53. Oishi Y., Manabe I., Tobe K., Tsushima K., Shindo T., Fujiu K., Nishimura G., Maemura K., Yamauchi T., Kubota N., Suzuki R., Kitamura T., Akira S., Kadowaki T., Nagai R. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 2005, 1:27-39.
54. Mori T., Sakaue H., Iguchi H., Gomi H., Okada Y., Takashima Y., Nakamura K., Nakamura T., Yamauchi T., Kubota N., Kadowaki T., Matsuki Y., Ogawa W., Hiramatsu R., Kasuga M. Role of Krüppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J. Biol. Chem. 2005, 280:12867-12875.
55. Kim J.B., Spiegelman B.M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 1996, 10:1096-1107.
56. Kim J.B., Wright H.M., Wright M., Spiegelman B.M. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc. Nat. Acad. Sci. USA 1998, 95:4333-4337.
57. Tzameli I., Fang H., Ollero M., Shi H., Hamm J.K., Kievit P., Hollenberg A.N., Flier J.S. Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J. Biol. Chem. 2004, 279:36093-36102.
58. Nanbu-Wakao R., Morikawa Y., Matsumura I., Masuho Y., Muramatsu Ma., Senba E., Wakao H. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5. Mol. Endocrinol. 2002, 16:1565-1576.
59. Kawai M., Namba N., Mushiake S., Etani Y., Nishimura R., Makishima M., Ozono K. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J. Mol. Endocrinol. 2007, 38:19-34.
60. Teglund S., Mckay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D.M., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93:841-850.
61. Solomon M.J., Larsen P.L., Varshavsky A. Mapping protein DNA interactions invivo with formaldehyde - evidence that histone-H4 is retained on a highly transcribed gene. Cell 1988, 53:937-947.
62. Ren B., Robert F., Wyrick J.J., Aparicio O., Jennings E.G., Simon I., Zeitlinger J., Schreiber J., Hannett N., Kanin E., Volkert T.L., Wilson C.J., Bell S.P., Young R.A. Genome-wide location and function of DNA binding proteins. Science 2000, 290:2306-2309.
63. Barski A., Cuddapah S., Cui K.R., Roh T.Y., Schones D.E., Wang Z.B., Wei G., Chepelev I., Zhao K.J. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
64. Johnson D.S., Mortazavi A., Myers R.M., Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-1502.
65. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W.L., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
66. John S., Sabo P.J., Johnson T.A., Sung M.H., Biddie S.C., Lightman S.L., Voss T.C., Davis S.R., Meltzer P.S., Stamatoyannopoulos J.A., Hager G.L. Interaction of the glucocorticoid receptor with the chromatin landscape. Mol. Cell 2008, 29:611-624.
67. Denissov S., van Driel M., Voit R., Hekkelman M., Hulsen T., Hernandez N., Grummt I., Wehrens R., Stunnenberg H. Identification of novel functional TBP-binding sites and general factor repertoires. EMBO J. 2007, 26:944-954.
68. Euskirchen G.M., Rozowsky J.S., Wei C.L., Lee W.H., Zhang Z.D.D., Hartman S., Emanuelsson O., Stolc V., Weissman S., Gerstein M.B., Ruan Y.J., Snyder M. Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Genome Res. 2007, 17:898-909.
69. Nielsen R., Pedersen T.Å., Hagenbeek D., Moulos P., Siersbæk R., Megens E., Denissov S., Børgesen M., Francoijs K.J., Mandrup S., Stunnenberg H.G. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev. 2008, 22:2953-2967.
70. Lefterova M.I., Zhang Y., Steger D.J., Schupp M., Schug J., Cristancho A., Feng D., Zhuo D., Stoeckert C.J., Liu X.S., Lazar M.A. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008, 22:2941-2952.
71. Hamza M.S., Pott S., Vega V.B., Thomsen J.S., Kandhadayar G.S., Ng P.W.P., Chiu K.P., Pettersson S., Wei C.L., Ruan Y., Liu E.T. De-Novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis. PLoS ONE 2009, 4:e4907.
72. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 1992, 358:771-774.
73. Ijpenberg A., Jeannin E., Wahli W., Desvergne B. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA - a functional analysis of the malic enzyme gene PPAR response element. J. Biol. Chem. 1997, 272:20108-20117.
74. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., Wang Q., Bekiranov S., Sementchenko V., Fox E.A., Silver P.A., Gingeras T.R., Liu X.S., Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38:1289-1297.
75. So A.Y.-L., Chaivorapol C., Bolton E.C., Li H., Yamamoto K.R. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet. 2007, 3:e94.
76. Wang Q.B., Li W., Liu X.S., Carroll J.S., Janne O.A., Keeton E.K., Chinnaiyan A.M., Pienta K.J., Brown M. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 2007, 27:380-392.
77. Pike J.W., Meyer M.B., Watanuki M., Kim S., Zella L.A., Fretz J.A., Yamazaki M., Shevde N.K. Perspectives on mechanisms of gene regulation by 1, 25-dihydroxyvitamin D-3 and its receptor. J. Steroid Biochem. Mol. Biol. 2007, 103:389-395.
78. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., Chew E.G.Y., Huang P.Y.H., Welboren W.J., Han Y., Ooi H.S., Ariyaratne P.N., Vega V.B., Luo Y., Tan P.Y., Choy P.Y., Wansa K.D.S., Zhao B., Lim K.S., Leow S.C., Yow J.S., Joseph R., Li H., Desai K.V., Thomsen J.S., Lee Y.K., Karuturi R.K.M., Herve T., Bourque G., Stunnenberg H.G., Ruan X., Cacheux-Rataboul V., Sung W.K., Liu E.T., Wei C.L., Cheung E., Ruan Y. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
79. Bugge A., Siersbaek M., Madsen M.S., Göndör A., Rougier C., Mandrup S. A novel intronic peroxisome proliferator activated receptor (PPAR) gamma enhancer in the uncoupling protein (UCP) 3 gene as a regulator of both UCP2 and -3 expression in adipocytes. J. Biol. Chem. 2010, 285:17310-17317.
80. Lefterova M.I., Steger D.J., Zhuo D., Qatanani M., Mullican S.E., Tuteja G., Manduchi E., Grant G.R., Lazar M.A. Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages. Mol. Cell Biol. 2010, 30:2078-2089.
81. Nakachi Y., Yagi K., Nikaido I., Bono H., Tonouchi M., Schönbach C., Okazaki Y. Identification of novel PPARgamma target genes by integrated analysis of ChIP-on-chip and microarray expression data during adipocyte differentiation. Biochem. Biophys. Res. Commun. 2008, 372:362-366.
82. Wakabayashi Ki., Okamura M., Tsutsumi S., Nishikawa N.S., Tanaka T., Sakakibara I., Kitakami Ji., Ihara S., Hashimoto Y., Hamakubo T., Kodama T., Aburatani H., Sakai J. The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol. Cell Biol. 2009, 29:3544-3555.
83. Kininis M., Chen B.S., Diehl A.G., Isaacs G.D., Zhang T., Siepel A.C., Clark A.G., Kraus W.L. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol. Cell Biol. 2007, 27:5090-5104.
84. Fontaine C., Dubois G., Duguay Y., Helledie T., Vu-Dac N., Gervois P., Soncin F., Mandrup S., Fruchart J.C., Fruchart-Najib J., Staels B. The orphan nuclear receptor rev-erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation. J. Biol. Chem. 2003, 278:37672-37680.
85. Mouthiers A., Baillet A., Delomenie C., Porquet D., Mejdoubi-Charef N. Peroxisome proliferator-activated receptor alpha physically interacts with CCAAT/enhancer binding protein (C/EBP beta) to inhibit C/EBP beta-responsive alpha 1-acid glycoprotein gene expression. Mol. Endocrinol. 2005, 19:1135-1146.
86. Boruk M., Savory J.G.A., Hache R.J.G. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor. Mol. Endocrinol. 1998, 12:1749-1763.